Tinjauan Penggunaan Artificial Intelligence pada Overactive Bladder Syndrome Wanita di daerah dengan Sumber Daya Terbatas

Edwin Armawan,(1*)

(1) Dep/SMF Obstetri & Ginekologi Fakultas Kedokteran Universitas Padjadjaran/RSUP. Dr. Hasan Sadikin Bandung, Indonesia
(*) Corresponding Author

Abstract


Overactive Bladder Syndrome merupakan keadaan yang ditandai dengan keluhan Urinary urgency, yang umumnya disertai frekuensi dan nocturia, dengan atau tanpa urgency urinary incontinence (UI), pada keadaan tidak ada infeksi saluran kemih atau patologi lain yang jelas terdapat.
Pada penelitian berbasis populasi didapatkan prevalensi OAB pada wanita berkisar antara 9-43%,2-9 dan meningkat sesuai dengan pertambahan usia10 walaupun didapatkan data pada beberapa penelitian prevalensinya menurun pada wanita diatas usia 60 tahun yang penyebab masih belum jelas.
Dampak OABS pada kehidupan seseorang antara lain dapat menyebabkan terganggunya fungsi social, aktivitas fisik, vitalitas, dan emosi sehingga pada akhirnya OABS dapat menyebabkan penurunan kualitas hidup secara bermakna, meningkatkan skor depresi, dan menurunkan kualitas tidur seseorang. Lebih jauh lagi efek dari OABS dapat menyebabkan patah tulang pada orang tua akibat jatuh karena kehilangan keseimbangan saat terbangun dari tidur malam karena akan berkemih.


Keywords


Syndrome, infeksi saluran kemih

Full Text:

PDF

References


Bo K, Frawley HC, Haylen BT, Abramov Y, Almeida FG, Berghmans B, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. Int Urogynecol J. 2016; DOI 10.1007/s00192-016−3123−4.

Choo MS, Ku JH, Lee JB et al. Cross-cultural differences for adapting overactive bladder symptoms: results of an epidemiologic survey in Korea. World J Uro 2007; 25: 505.

Corcos J and Schick E. Prevalence of overactive bladder and incontinence in Canada. Can J Urol 2004; 11: 2278.

Coyne KS, Sexton CC, Vats V et al: National community prevalence of overactive bladder in the United States stratified by sex and age. Urology 2011; 77: 1081.

Tikkinen, KA, Auvinen A, Tiitinen A. et al. Reproductive factors associated with nocturia and urinary urgency inin women: A population-based study in Finland. Am J Obstet Gynecol 2008: 199: 153 e1.

Irwin DE, Milsom I, Hunskaar S et al: Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study. Eur Urol 2006; 50: 1306.

Stewart WF, Van Rooyen JB, Cundiff GW et al: Prevalence and burden of overactive bladder in the United States. World J Uro 2003; 20: 327.

Herschorn S, Gajewski J, Schulz J, et al: A population-based study of urinary symptoms and incontinence: The Canadian Urinary Bladder Survery. BJU Int 2008; 101; 52.

Milsom I, Abrams P, Cardozo L et al: How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Intl 2001; 87: 760

Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001 Jun; 87(9):760−6.

Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003 May; 20(6):327-36.

Lee YS, Lee KS, Jung JH, Han DH, Oh SJ, Seo JT, Lee JG, Park HS, Choo MS. Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms: results of Korean EPIC study. World J Urol. 2011 Apr; 29(2):185−90.

Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003 May. 20(6):327-36.

Winters C, Dmochowski RR, Goldman HB, Herndon AC, Kobashi KC, Kraus SR, Lemack GE, Nitti VW, Rovner ES, Wein AJ.

Diagnosis and Treatment of Non-Neurogenic Overactive Bladder (OAB) in Adults: an AUA/SUFU Guideline (2019). American Urological Association Clinical Guideline.

Murray B, Hessami SH, Gultyaev D, Lister J, Dmochowski R, Gillard KK, Stanisic S,Tung Amy, Boer R, Kaplan S. Cost–effectiveness of overactive bladder treatments: from the US payer perspective. Journal Of Comparative Effectiveness Research. vol. 8, No. 1. 2018.

Ardiansyah E. Pengaruh Ekstrak Buah Mengkudu (Morinda Citrifolia) terhadap Kadar Malondialdehid, Nerve Growth Factor dan High Sensitivity C-Reactive Protelnpada Wanita Overactive Bladder. Repositori Institusi Universitas Sumatera Utara (RI-USU). 2020.




DOI: http://dx.doi.org/10.24198/obgynia/v5n1.376

Refbacks

  • There are currently no refbacks.





     
       

Creative Commons License
Indonesian Journal of Obstetrics & Gynecology Science is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
  Web Analytics
  View My Stat